Chronic Stroke: Clinical Trials

3 trials for Chronic Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Chronic Stroke: new trials by email Literature Review of Chronic Stroke trials Research Report on Chronic Stroke

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-labeled Phase II Study to Evaluate the Efficacy and Safety of GXNPC-1 in Patients with Chronic Stroke
GXNPC1 - Chronic Stroke
Phase 2CompletedGwo Xi Stem Cell Applied Technology Co., Ltd.122020-02-062024-09-19
Effects of EMG-driven Robot-assisted Therapy for the Distal Upper Limb Motor Function in the Chronic Stroke Patients With Botox Injections
Hand of Hope, Botulinum toxin type A injection - Chronic Stroke, Spasticity as Sequela of Stroke
Phase 2CompletedCheng-Hsin General Hospital242020-01-092024-03-19
Influence of G-CSF and EPO on Associative Learning and Motor Skills
granulocyte - colony stimulating factor (G-CSF), erythropoetin (EPO) - Chronic Stroke, Amyotrophic Lateral Sclerosis
Phase 2CompletedUniversity Hospital Muenster1802006-03-012009-04-23

Narrower conditions

Amyotrophic Lateral Sclerosis (1)

Broader conditions

Central Nervous System Diseases (1)  ·  Metabolic Diseases (1)  ·  Motor Neuron Disease (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Proteostasis Deficiencies (1)  ·  Spinal Cord Diseases (1)  ·  TDP-43 Proteinopathies (1)

Interventions

Botulinum Toxins, Type A (1)  ·  Erythropoietin (1)  ·  Granulocyte Colony-Stimulating Factor (1)

Sponsors

Cheng-Hsin General Hospital (1)  ·  Gwo Xi Stem Cell Applied Technology Co., Ltd. (1)  ·  University Hospital Muenster (1)

Countries

Taiwan (2)  ·  Germany (1)

Top investigators

Chiu Ts Lang, Director (1)

Results publications

PMID 21423758, PMID 21625426